SPC
RNLX

Slate Path Capital’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Slate Path Capital’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-175,214
Closed -$224K – 50
2022
Q3 		$224K Hold
175,214
– – 0.01% 45
2022
Q2 		$429K Hold
175,214
– – 0.03% 43
2022
Q1 		$1.21M Hold
175,214
– – 0.06% 37
2021
Q4 		$2.79M Buy
+175,214
New +$3.51M 0.15% 33

Other funds holding RNLX

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Slate Path Capital's RNLX Position: Q4 2022 in Review

Slate Path Capital sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2022, closing a stake of 175,214 shares — an estimated $224K sold.

Slate Path Capital first reported a position in RNLX in Q4 2021 and held it in 4 quarters. The position peaked at $2.79M in Q4 2021. 21 funds tracked by Wall St. Rank hold RNLX as of Q4 2022.

  • Slate Path Capital reported no remaining Renalytix plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Slate Path Capital sold 175,214 Renalytix plc American Depositary Shares shares in Q4 2022, an estimated $224K.
  • Slate Path Capital first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Slate Path Capital's Renalytix plc American Depositary Shares position peaked at $2.79M in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2022.

Based on Slate Path Capital's 13F filing for Q4 2022, filed 14 Feb 2023.